PubMed

alpha-Dicarbonyls increase in the postprandial period and reflect the degree of hyperglycemia.

Beisswenger PJ, Howell SK, O'Dell RM, Wood ME, Touchette AD, Szwergold BS.

Diabetes Care. 2001 Apr;24(4):726-32.PMID: 11315838 [PubMed - indexed for MEDLINE]Related articlesFree article

Glycated and oxidized protein degradation products are indicators of fasting and postprandial hyperglycemia in diabetes.

Ahmed N, Babaei-Jadidi R, Howell SK, Thornalley PJ, Beisswenger PJ.

Diabetes Care. 2005 Oct;28(10):2465-71.PMID: 16186281 [PubMed - indexed for MEDLINE]Related articlesFree article

[The features of postprandial glucose state in type 2 diabetes mellitus]

Zhou J, Jia WP, Yu M, Ma XJ, Bao YQ, Lu W.

Zhonghua Yi Xue Za Zhi. 2006 Apr 11;86(14):970-5. Chinese. PMID: 16759538 [PubMed - indexed for MEDLINE]Related articles

Pramlintide reduces postprandial glucose excursions when added to regular insulin or insulin lispro in subjects with type 1 diabetes: a dose-timing study.

Weyer C, Gottlieb A, Kim DD, Lutz K, Schwartz S, Gutierrez M, Wang Y, Ruggles JA, Kolterman OG, Maggs DG.

Diabetes Care. 2003 Nov;26(11):3074-9.PMID: 14578242 [PubMed - indexed for MEDLINE]Related articlesFree article

Contribution of postprandial versus interprandial blood glucose to HbA1c in type 1 diabetes on physiologic intensive therapy with lispro insulin at mealtime.

Ciofetta M, Lalli C, Del Sindaco P, Torlone E, Pampanelli S, Mauro L, Chiara DL, Brunetti P, Bolli GB.

Diabetes Care. 1999 May;22(5):795-800.PMID: 10332684 [PubMed - indexed for MEDLINE]Related articlesFree article

The effect of the insulin analog lispro on nighttime blood glucose control in type 1 diabetic patients.

Ahmed AB, Home PD.

Diabetes Care. 1998 Jan;21(1):32-7.PMID: 9538967 [PubMed - indexed for MEDLINE]Related articlesFree article

Comparison of insulin lispro with regular human insulin for the treatment of type 1 diabetes in adolescents.

Holcombe JH, Zalani S, Arora VK, Mast CJ; Lispro in Adolescents Study Group.

Clin Ther. 2002 Apr;24(4):629-38.PMID: 12017407 [PubMed - indexed for MEDLINE]Related articles

Intensive insulin therapy with insulin lispro in patients with type 1 diabetes reduces the frequency of hypoglycemic episodes.

Pfützner A, Küstner E, Forst T, Schulze-Schleppinghoff B, Trautmann ME, Haslbeck M, Schatz H, Beyer J.

Exp Clin Endocrinol Diabetes. 1996;104(1):25-30.PMID: 8750567 [PubMed - indexed for MEDLINE]Related articles

Optimal administration of lispro insulin in hyperglycemic type 1 diabetes.

Rassam AG, Zeise TM, Burge MR, Schade DS.

Diabetes Care. 1999 Jan;22(1):133-6.PMID: 10333914 [PubMed - indexed for MEDLINE]Related articlesFree article

Optimal provision of daytime NPH insulin in patients using the insulin analog lispro.

Ahmed AB, Home PD.

Diabetes Care. 1998 Oct;21(10):1707-13.PMID: 9773735 [PubMed - indexed for MEDLINE]Related articlesFree article

Humalog Mix 25 in patients with type 2 diabetes which do not achieve acceptable glycemic control with oral agents: results from a phase III, randomized, parallel study.

Tîrgovişte CI, Străchinariu R, Farcaşiu E, Milicevic Z, Teodorescu G.

Rom J Intern Med. 2003;41(2):153-62.PMID: 15526500 [PubMed - indexed for MEDLINE]Related articles

Premeal insulin lispro plus bedtime NPH or twice-daily NPH in patients with type 2 diabetes: acute postprandial and chronic effects on glycemic control and cardiovascular risk factors.

Ceriello A, Del Prato S, Bue-Valleskey J, Beattie S, Gates J, de la Peña A, Malone J.

J Diabetes Complications. 2007 Jan-Feb;21(1):20-7.PMID: 17189870 [PubMed - indexed for MEDLINE]Related articles

Metformin reduces systemic methylglyoxal levels in type 2 diabetes.

Beisswenger PJ, Howell SK, Touchette AD, Lal S, Szwergold BS.

Diabetes. 1999 Jan;48(1):198-202.PMID: 9892243 [PubMed - indexed for MEDLINE]Related articlesFree article

Metabolic efficacy of preprandial administration of Lys(B28), Pro(B29) human insulin analog in IDDM patients. A comparison with human regular insulin during a three-meal test period.

Jacobs MA, Keulen ET, Kanc K, Casteleijn S, Scheffer P, Devillé W, Heine RJ.

Diabetes Care. 1997 Aug;20(8):1279-86.PMID: 9250454 [PubMed - indexed for MEDLINE]Related articles

Preprandial vs. postprandial insulin lispro-a comparative crossover trial in patients with Type 1 diabetes.

Schernthaner G, Wein W, Shnawa N, Bates PC, Birkett MA.

Diabet Med. 2004 Mar;21(3):279-84.PMID: 15008840 [PubMed - indexed for MEDLINE]Related articles

Postprandial insulin lispro. A new therapeutic option for type 1 diabetic patients.

Schernthaner G, Wein W, Sandholzer K, Equiluz-Bruck S, Bates PC, Birkett MA.

Diabetes Care. 1998 Apr;21(4):570-3.PMID: 9571344 [PubMed - indexed for MEDLINE]Related articlesFree article

Pramlintide reduces postprandial glucose excursions when added to insulin lispro in subjects with type 2 diabetes: a dose-timing study.

Maggs DG, Fineman M, Kornstein J, Burrell T, Schwartz S, Wang Y, Ruggles JA, Kolterman OG, Weyer C.

Diabetes Metab Res Rev. 2004 Jan-Feb;20(1):55-60.PMID: 14737746 [PubMed - indexed for MEDLINE]Related articles

Improved glycemic control with insulin aspart: a multicenter randomized double-blind crossover trial in type 1 diabetic patients. UK Insulin Aspart Study Group.

Home PD, Lindholm A, Hylleberg B, Round P.

Diabetes Care. 1998 Nov;21(11):1904-9.PMID: 9802741 [PubMed - indexed for MEDLINE]Related articlesFree article

Control of postprandial hyperglycemia: optimal use of short-acting insulin secretagogues.

Carroll MF, Izard A, Riboni K, Burge MR, Schade DS.

Diabetes Care. 2002 Dec;25(12):2147-52.PMID: 12453952 [PubMed - indexed for MEDLINE]Related articlesFree article

Strategies toward improved control during insulin lispro therapy in IDDM. Importance of basal insulin.

Ebeling P, Jansson PA, Smith U, Lalli C, Bolli GB, Koivisto VA.

Diabetes Care. 1997 Aug;20(8):1287-9.PMID: 9250455 [PubMed - indexed for MEDLINE]Related articles